128.48, 129.30, 129.43, 129.49, 130.45, 130.70, 131.05, 133.88,
134.10, 134.42, 137.82, 137.93, 143.97, 144.31. HRMS m/z: Calcd
for C31H35OPS (M+): 486.2146. Found: 486.2063.
139.76, 139.94. Anal. Calcd for C31H35Cl2OPSPd: C, 56.08; H,
5.31. Found: C, 56.09; H, 5.30. MS m/z: 662 (M+).
Dich lor o[(1R,3R,5R,8S)-11,11-d im eth yl-4-oxa -5-[2-d i(3,3-
xylyl)p h osp h in o]p h en yl-6-th ia tr icyclo[6.2.1.0]u n d eca n e]-
p a lla d iu m (11d ): yield, 91%; yellow crystals. mp 209-210 °C.
(1R,3R,5R,8S)-11,11-Dim et h yl-4-oxa -5-[2-d i(3,3-xylyl)-
ph osph in o]ph en yl-6-th iatr icyclo[6.2.1.0]u n decan e (3): yield,
83% ; white solid. mp 38-42 °C. [R]23 ) -84.8 (c 2.1, CHCl3).
[R]20 ) -109.7 (c 2.2, CHCl3). IR (KBr) cm-1: 847, 732, 688. 1H
D
D
IR cm-1: 847, 747, 693. H NMR (CDCl3) δ: 0.86-1.06 (m, 5H),
1
NMR (CDCl3) δ: 0.89-1.09 (m, 5H), 1.30 (s, 3H), 1.71-1.83 (m,
4H), 2.11 (m, 1H), 2.32(d, J ) 16.0 Hz, 12H), 3.56 (m, 1H), 3.64
(d, J ) 14.2 Hz, 1H), 4.12 (d, J ) 14.2 Hz, 1H), 5.41 (s, 1H),
6.69 (m, 1H), 7.02 (d, J ) 13.7 Hz, 2H), 7.12 (s, 1H), 7.25 (s,
1H), 7.34 (t, J ) 7.7 Hz, 1H), 7.48 (d, J ) 13.4 Hz, 2H), 7.61 (t,
J ) 7.7 Hz, 1H), 7.89 (m, 1H). 13C NMR (CDCl3) δ: 20.19, 21.39,
21.45, 23.01, 27.10, 33.68, 37.40, 39.94, 45.49, 45.72, 47.13, 81.91,
86.46, 125.49, 125.62, 129.22, 129.35, 131.98, 132.08, 132.11,
133.64, 133.68, 133.81, 133.87, 134.85, 137.86, 138.05, 138.79,
138.91, 139.25, 139.43. HRMS m/z: Calcd for C33H39Cl2OPSPd
(M+): 690.0871. Found: 690.0944.
1.41-1.54 (m, 4H), 1.60-1.71 (m, 3H), 1.91 (m, 1H), 2.24 (s,
12H), 2.71 (d, J ) 14.4 Hz, 1H), 3.20 (d, J ) 14.4 Hz, 1H), 3.59
(m, 1H), 6.37 (d, J ) 7.75 Hz, 1H), 6.89-6.98 (m, 7H), 7.18 (m,
1H), 7.37 (m, 1H), 7.71 (m, 1H). 13C NMR (CDCl3) δ: 20.22,
21.43, 21.48, 23.04, 27.13, 30.93, 33.71, 37.43, 39.98, 45.52, 45.75,
47.17, 81.95, 86.50, 127.21, 127.29, 128.42, 129.41, 130.26,
130.40, 131.06, 131.35, 131.39, 131.67, 133.91, 137.62, 137.72,
143.95, 144.29. HRMS m/z: Calcd for C33H39OPS (M+): 514.2459.
Found: 514.2485.
(1R,3R,5R,8S)-11,11-Dim eth yl-4-oxa -5-[2-d i(1-n a p h th yl)-
ph osph in o]ph en yl-6-th iatr icyclo[6.2.1.0]u n decan e (4): yield,
Dich lor o[(1R,3R,5R,8S)-11,11-d im et h yl-4-oxa -5-[2-d i(1-
n a p h t h y l)p h o s p h i n o ]p h e n y l-6-t h i a t r i c y c lo [6.2.1.0]-
u n d eca n e]p a lla d iu m (11e): yield, 85%; yellow crystals. mp
65%; white solid. mp 71-74 °C. [R]24 ) -40.8 (c 1.3, CHCl3).
D
IR (KBr) cm-1: 798, 774, 746. H NMR (CDCl3) δ: 0.76-0.97(m,
1
204-208 °C. [R]22 ) -97.5 (c 2.4, CHCl3). IR (KBr) cm-1: 800,
D
5H), 1.33-1.46 (m, 4H), 1.54 (s, 1H), 1.65-1.68 (m, 2H), 1.81
(m, 1H), 2.67 (d, J )14.2 Hz, 1H), 3.08 (d, J ) 14.2 Hz, 1H),
3.53 (brs, 1H), 6.49 (d, J ) 7.42 Hz, 1H), 6.84 (m, 1H), 6.94-
7.11 (m, 3H), 7.28-7.51 (m, 7H), 7.75-7.89 (m, 5H), 8.40-8.51
(m, 2H). 13C NMR (CDCl3) δ: 20.44, 23.41, 27.20, 29.95, 34.16,
37.81, 41.86, 45.53, 46.75, 81.33, 85.58, 125.66, 125.68, 125.78,
125.92, 126.24, 126.37, 126.46, 126.76, 126.85, 127.46, 127.53,
128.56, 128.59, 128.71, 129.47, 129.51, 129.82, 133.12, 133.17,
133.42, 133.43, 133.49, 134.63, 135.51, 144.06, 144.42. HRMS
m/z: Calcd for C37H35OPS (M+): 558.2146. Found: 558.2196.
Gen er a l P r oced u r e for P r ep a r a tion of P d Cl2- a n d
P tCl2-P h osp h in ooxa th ia n e Com p lexes (11a -e, 13). PdCl2
(0.035 mmol) or PtCl2 (0.035 mmol) and phosphinooxathianes
1-5 (0.035 mmol) were suspended in 1,2-dichloroethane (2 mL)
under Ar. The mixture was refluxed for 6h and the resulting
yellow solution was cooled and filtered. The filtrate was con-
densed under a reduced pressure and the residue was recrystal-
lized from hexane: CH2Cl2 to afford 11a -e and 13.
1
772, 746. H NMR (CDCl3) δ: 0.83-1.06 (m, 5H), 1.25-1.47 (m,
3H), 1.58-1.78 (m, 4H), 1.99 (d, J ) 13.4 Hz, 1H), 3.22 (m, 1H),
3.64 (d, J ) 14.0 Hz, 1H), 4.18 (d, J ) 14.0 Hz, 1H), 5.08 (s,
1H), 7.18-8.18 (m, 15H), 8.25 (d, J ) 8.4 Hz, 1H), 8.69 (d, J )
7.8 Hz, 1H), 10.01 (dd, J ) 6.9 Hz, 20.0 Hz, 1H). 13C NMR
(CDCl3) δ: 20.22, 22.99, 27.05, 33.94, 37.22, 40.38, 45.46, 45.84,
47.13, 82.09, 86.92, 124.41, 124.60, 124.52, 125.79, 125.90,
125.95, 126.80, 127.53, 127.62, 128.81, 128.94, 129.06, 129.36,
129.81, 130.89, 132.13, 132.46, 133.28, 133.62, 133.75, 134.25,
134.34, 134.91, 135.38, 138.75, 143.64.
Dich lor o[(1R,3S,5S,8S)-11,11-dim eth yl-4-oxa-5-(2-diph en -
ylphosphino)phenyl-6-thiatricyclo[6.2.1.0]undecane]palladium
(13): yield, 91%; yellow crystals. mp 204-207 °C. [R]20 ) 74.8
D
(c 2.5, CHCl3). IR (KBr) cm-1: 769, 750, 694. 1H NMR (CDCl3)
δ: 0.95 (d, J ) 13.4 Hz, 6H), 1.24 (m, 1H), 1.38 (m, 1H), 1.54 (m,
1H), 1.81-1.82 (m, 2H), 2.21-2.43 (m, 2H), 3.68-3.79 (m, 2H),
3.93 (d, J ) 12.7 Hz, 1H), 5.66 (s, 1H), 6.68 (m, 1H), 7.35-7.57
(m, 8H), 7.63-7.70 (m, 2H), 7.90-8.05 (m, 3H). 13C NMR (CDCl3)
δ: 18.62, 19.52, 24.83, 27.95, 33.94, 44.27, 45.31, 46.21, 48.73,
84.32, 85.75, 124.99, 125.95, 126.83, 128.44, 128.63, 129.54,
129.72, 129.81, 131.83, 132.58, 132.94, 133.65, 134.30, 134.46,
Dich lor o[(1R,3R,5R,8S)-11,11-dim eth yl-4-oxa-5-(2-diph en -
ylph osph in o)ph en yl-6-th iatr icyclo[6.2.1.0]u n decan e]palladi-
u m (11a ): yield, 95%; yellow crystals. mp 238-241 °C. [R]23
)
D
-159.2 (c 2.5, CHCl3). IR (KBr) cm-1: 747, 710, 692. 1H NMR
(CDCl3) δ: 0.88-1.09 (m, 5H), 1.29 (s, 3H), 1.59-1.83 (m, 4H),
2.12 (m, 1H), 3.53 (m, 1H), 3.64 (d, J ) 14.4, 1H), 4.13 (d, J )
14.2, 1H), 5.40 (s, 1H), 6.70 (m, 1H), 7.32-7.64 (m, 10H), 7.93
(m, 3H). 13C NMR (CDCl3) δ: 20.17, 22.99, 27.07, 33.65, 37.33,
40.02, 45.45, 45.73,47.11, 82.01, 86.59, 125.84, 125.97, 128.40,
128.59, 129.53, 129.62, 129.79, 131.79, 131.83, 132.43, 132.46,
132.95, 133.00, 134.34, 134.50, 134.80, 134.97, 139.02. Anal.
Calcd for C29H31Cl2OPSPd: C, 54.77; H, 4.91. Found: C, 54.65;
H, 4.89. MS m/z: 634 (M+).
134.92, 135.09, 138.63, 138.75. HRMS m/z: Calcd for C29H31
-
Cl2OPSPd: 634.0245. Found: 634.0153.
Gen er a l P r oced u r e for En a n tioselective P d (II) a n d P t-
(II)-Ca ta lyzed Diels-Ald er Rea ction s. PdCl2-POT com-
plexes 11a , 11c-e, 13 (1 equiv) or PtCl2-POT complex 11b (1
equiv) and appropriate silver salt (2 equiv) in CH2Cl2 (1 mL)
were stirred at room temperature under Ar for 1 h. The catalyst
complex was then cooled to the temperature as shown in Table
1, and acryloyl-1,3-oxazolidin-2-one 6a (50 mg, 0.36 mmol) or
fumaroyl-1,3-oxazolidin-2-one 6b (77 mg, 0.36 mmol) in CH2Cl2
(1 mL) followed by cyclopentadiene (117 mg, 1.77 mmol) was
added. The reaction mixture was stirred for the specified amount
of time and quenched with sat. aq NaHCO3. The mixture was
extracted with CHCl3, and the organic layer was washed with
brine and dried over MgSO4. Evaporation of the solvent under
a reduced pressure afforded a crude residue that was purified
by column chromatograpy on silica gel (elution with AcOEt:
hexane ) 1:4) to give the cycloadducts 7a ,b. The ee of 7a was
determined by HPLC (Chiralcel OD-H, 1.0 mL/min, hexane:2-
propanol ) 90:10). The ee of 7b was determined by comparison
of the known optical rotation of iodolactonization product derived
from 7b.3e
Dich lor o[(1R,3R,5R,8S)-11,11-dim eth yl-4-oxa-5-(2-diph en -
ylph osph in o)ph en yl-6-th iatr icyclo[6.2.1.0]u n decan e]platin -
u m (11b): yield, 90%; colorless crystals. mp 211-214 °C. [R]23
D
) -122.4 (c 2.0, CHCl3). IR (KBr) cm-1: 748, 713, 696. 1H NMR
(CDCl3) δ: 0.86-1.09 (m, 5H), 1.29 (s, 3H), 1.62-1.82 (m, 4H),
2.13 (m, 1H), 3.57-3.62 (m, 2H), 4.11 (d, J ) 14.0, 1H), 5.45 (s,
1H), 6.62-6.70 (m, 1H), 7.32-7.65 (m, 10H), 7.81-7.94 (m, 3H).
13C NMR (CDCl3) δ: 20.24, 22.91, 27.11, 33.51, 37.36, 39.99,
45.49, 45.86, 47.13, 81.29, 86.61, 125.62, 125.74, 128.23, 128.41,
129.19, 129.33, 129.49, 131.73, 131.77, 132.17, 132.20, 132.60,
132.64, 134.46, 134.49, 134.61, 134.66, 138.44. HRMS m/z: Calcd
for C29H31Cl2OPSPt: 723.0858. Found: 723.0629.
Dich lor o[(1R,3R,5R,8S)-11,11-d im eth yl-4-oxa -5-[2-d i(m -
tolyl)p h osp h in o]p h en yl-6-th ia tr icyclo[6.2.1.0]u n d eca n e]-
X-r a y Cr ysta l Str u ctu r e of P d Cl2-P OT (11a ). X-ray
crystallographic data of PdCl2-POT (11a ) have been deposited
at the Cambridge Crystallographic Data Center (CCDC 186659)
in CIF format.
p a lla d iu m (11c): yield, 95%; yellow crystals. mp 203-205 °C.
1
[R]20 ) -127.1 (c 2.2, CHCl3). IR (KBr) cm-1: 780, 706,691. H
D
NMR (CDCl3) δ: 0.89-1.09(m, 5H), 1.29 (s, 3H), 1.61-1.83 (m,
4H), 2.11 (m, 1H), 2.38(d, J ) 19.5 Hz, 6H), 3.54 (m, 1H), 3.65
(d, J ) 14.4 Hz, 1H), 4.13 (d, J ) 14.4 Hz, 1H), 5.42 (s, 1H),
6.69 (m, 1H), 7.17 (m, 1H), 7.29-7.47 (m, 6H), 7.50-7.65 (m,
2H), 7.85-7.92 (m, 2H). 13C NMR (CDCl3) δ: 20.22, 21.55, 21.63,
23.04, 27.12, 33.70, 37.40, 40.01, 45.50, 45.76, 47.16, 82.00, 86.56,
125.68, 125.81, 129.26, 129.44, 132.27, 132.31, 132.67, 133.77,
133.83, 133.85, 133.89, 134.88, 138.21, 138.40, 138.86, 138.99,
Su p p or tin g In for m a tion Ava ila ble: Experimental in-
formation including structural data for compounds 9a -c, and
1H and 13C NMR spectra data of compounds 2-4, 9a -c, 10a -
c, 11a -e, and 13. This material is available free of charge
J O0201474
5014 J . Org. Chem., Vol. 67, No. 14, 2002